Non-Hodgkin lymphoma is a cancer that affects lymphocytes ... to the cancer's growth rate as high grade (fast growing) or low grade (slow growing).

Incyte (Nasdaq: INCY) today announced that the Company will present new data from across its oncology portfolio at the 2024 American Society of Hematology (ASH) Annual Meeting in San Diego.

Phase 1 Basket Study for B Cell-mediated Autoimmune Diseases to Assess FT522 as Add-on to Standard-of-care Induction and Maintenance Regimens ...

CD19 t-haNK as a single agent and in combination with rituximab in participants with selected CD19+ and CD20+ R/R B-cell non-Hodgkin lymphoma (NHL). Participants will initially receive a single 3 ...

Many low-grade lymphomas remain indolent for years ... Newer chemotherapy drugs include Treanda (bendamustine), an intravenous drug used for people with indolent B-cell lymphoma, and the injectable ...

ibrutinib), and the B-cell lymphoma (BCL)-2 inhibitor venetoclax. 48 These suggestions were further substantiated by an evaluation of duvelisib in combination with dexamethasone, ibrutinib ...